发明名称 Active immunization for treatment of alzheimer's disease
摘要 The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of Abeta in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the amyloid deposit. The methods are useful for prophylactic and therapeutic treatment of Alzheimer's disease. Preferred agents including N-terminal fragments of Abeta and antibodies binding to the same.
申请公布号 US6905686(B1) 申请公布日期 2005.06.14
申请号 US20000724940 申请日期 2000.11.28
申请人 NEURALAB LIMITED 发明人 SCHENK DALE B.
分类号 A61K38/00;A61K38/17;A61K38/19;A61K39/00;C07K14/47;C07K16/18;(IPC1-7):A61K38/00;A61K39/39 主分类号 A61K38/00
代理机构 代理人
主权项
地址